Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00675_DB01026_nanopub.RAKaIXbzib5nJgZTMgdyNLV5wFywwrGph415bIgKGrF-Y#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00675_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00675_DB01026 label "DDI between Tamoxifen and Ketoconazole - Ketoconazole may increase the serum concentration of Tamoxifen by decreasing its metabolism and clearance. Ketoconazole may also decrease the therapeutic effect of Tamoxifen by decreasing active metabolite production. Monitor for changes in the therapeutic/adverse effects of Tamoxifen if Ketoconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00675_DB01026]" assertion.
- drugbank_resource:DB00675_DB01026 identifier "drugbank_resource:DB00675_DB01026" assertion.
- drugbank_resource:DB00675_DB01026 title "DDI between Tamoxifen and Ketoconazole - Ketoconazole may increase the serum concentration of Tamoxifen by decreasing its metabolism and clearance. Ketoconazole may also decrease the therapeutic effect of Tamoxifen by decreasing active metabolite production. Monitor for changes in the therapeutic/adverse effects of Tamoxifen if Ketoconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00675 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00675_DB01026 assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00675_DB01026 assertion.